Book Value per Share: Ascentage Pharma Group (AAPGV)

Graphic logo of Ascentage Pharma Group (AAPGV)

Compliance with environmental regulations for reagent disposal requires expenditures, as confirmed by the book value per ordinary share, where the parameter settled at 0.88. The active implementation of innovative leukemia drugs, which expands the global presence of Ascentage Pharma Group (AAPGV) through strategic alliances, helps overcome geopolitical barriers in patent law and logistics.

AAPGV Ascentage Pharma Group International Net Assets per Single Share (01/25/2025 - 10/27/2026)

ascentage.com - analytical breakdowns and key metrics (AAPGV)

- price and consensus price forecast:
Price Chart Ascentage Pharma Group Ltd|AAPGV - Forecast Levels Chart
- market capitalization data:
Market Capitalization Ascentage Pharma Group|AAPGV - Full Takeover Company Value
- book capitalization data:
Accounting Value per Share Ascentage Pharma|AAPGV - Company Book Value|Market Capitalization to Book Value Ratio ascentage.com|AAPGV - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital Ascentage Pharma Group|AAPGV - Long-Term Debt to Capital|Short-Term Debt to Equity Ascentage Pharma|AAPGV - Company Aggregate Debt|Debts to Book Capitalization Ascentage Pharma Group
Analysis of all company metrics:Ascentage Pharma Group Ltd - AAPGV
Manufactured products of Ascentage Pharma

To protect portfolio capital, priority is given to assets with sustainable net asset growth, which is critical for Ascentage Pharma Group (AAPGV) during the period of costly clinical trials for oncology drugs. Assessing the financial cushion via book value per share allows for the measurement of residual asset value minus liabilities, reflecting capital management efficiency and the level of protection against bankruptcy.

Competitors of Ascentage Pharma Group (AAPGV)

Net Assets per Single Share BeiGene Corp|HALO - Share Book Value|Book Value per Share RVMD (Revolution Medicines)|Book Value of One Share ascentage.com|Accounting Value per Share CG Oncology|Net Assets per Single Share UroGen Pharma Ltd|Book Value per Share BCAX (Bicara Bio)|Accounting Value per Share Personalis Genomics (PSNL)|Book Value per Share ERAS (Erasca, Inc.)|delcath.com - Book Value per Share|Y-mAbs Therapeutics, Inc. (YMAB) - Net Assets per Single Share|AURA - Equity per Share|CADL (candeltx.com) - Book Value per Share|Accuray, Inc. (ARAY) - Accounting Value per Share|Book Value per Share SLS (SELLAS Life Sciences Group, Inc.)|Net Asset Value per Share ACTU|Citius Oncology (CTOR) - Net Assets per Single Share|Accounting Value of a Share tuhurabio.com HURA|Accounting Value per Share Protara|Accounting Value of a Share Fate Pharma FATE|WHWK: Book Value per Share|TScan Therapeutics (TCRX) - Accounting Value per Share|CSBR: Accounting Value per Share|XBIT (XBiotech) - Book Value per Share|CVM - Net Assets per Single Share|Accounting Value of a Share OS Therapies, Inc.|Radiopharm Theranostics Limited - Book Value per Share|Net Asset Value per Share artivabio.com (ARTV)|Book Value per Share ANL (Adlai Nortye)|Veru Inc - Book Value per Share|Net Assets per Single Share TPST (Tempest Tx)|XLO - Net Assets per Share|RENB (renovarobio.com) - Book Value per Share|Mural Oncology (MURA) - Accounting Value per Share|Book Value per Share KAPA (Kairos Pharma Limited)|Net Asset Value per Share OKUR|Net Assets per Single Share CytoMed Therapeutics GDTC|Equity per Share curis.com CRIS|Accounting Value per Share Apollomics (APLM)|Book Price of a Share tharimmune.com THAR|Advanced Biomed Corp - Book Value per Share|GNPX - Book Value per Share|Book Value per Share CLDI (calidibio.com)|Sunshine Biopharma Inc. (SBFM) - Book Value of One Share|Book Value per Share XBIO (Xenetic Biosciences Inc.)|Net Asset Value per Share salariuspharma.com (SLRX)|Purple Biotech Ltd. (PPBT) - Accounting Value per Share|Accounting Value of a Share AONC (aoncology.com)|BeOne Medicines (BGNE) - Net Assets per Single Share|Share Book Value Checkpoint Therapeutics Inc CKPT|Book Value per Share Elevation Oncology, Inc. (ELEV)|ICAD - Accounting Value of a Share|IKNA: Book Value per Share|NTBL (Notable Labs Ltd) - Book Value per Share|VIRX - Net Assets per Single Share|Accounting Value of a Share MOR|Net Assets per Single Share NAYA (NAYA Biosciences)